Markets:

Overview

News

Currencies

International

Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.97 +0.11 (+0.65%)

Official Closing Price Updated: 4:10 PM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Kenvue to Announce Third Quarter 2025 Results on November 6, 2025

October 27, 2025

From Kenvue

Via Business Wire

3 Healthcare Stocks Paying the Highest Dividends of 2025 ↗

October 27, 2025

If you are looking for high yields in the healthcare sector, here are three choices. Make sure you understand the risks before you buy them.

Via The Motley Fool

Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever. ↗

October 26, 2025

Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).

Via The Motley Fool

Topics Government

Looking Into Kenvue Inc's Recent Short Interest ↗

October 21, 2025

Via Benzinga

Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken ↗

October 17, 2025

Via Stocktwits

Renaissance Capital Sells Off 176K CRBG Shares Worth $6.3 Million ↗

October 21, 2025

Via The Motley Fool

Topics Regulatory Compliance Retirement

These S&P500 stocks are gapping in today's session ↗

October 20, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Monday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October ↗

October 20, 2025

These three stocks have elevated yields and attractive dividend histories.

Via The Motley Fool

Meet the 5%-Yielding Dividend Stock That Could Soar in 2026 ↗

October 19, 2025

Kenvue could start to recover in 2026.

Via The Motley Fool

Johnson & Johnson's M&A Strategy Is the Real Story for Investors ↗

October 18, 2025

Johnson & Johnson’s rumored Protagonist buyout demonstrates its proven M&A strategy: divesting low-growth units to fund high-margin, innovative assets.

Via MarketBeat

Uncover the latest developments among S&P500 stocks in today's session. ↗

October 17, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗

October 17, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Which S&P500 stocks are moving on Friday? ↗

October 17, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

Why Kenvue Stock Tumbled by 13% on Thursday ↗

October 16, 2025

The company's baby powder product is under legal fire once again.

Via The Motley Fool

Topics Lawsuit

Kenvue's Dual Dilemma: Tylenol and Talc Fears Trigger Sector Jitters

October 16, 2025

New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of...

Via MarketMinute

Topics Death Government Lawsuit

Johnson & Johnson Plunges Amidst Escalating Talc Litigation: Billions at Stake as Legal Battles Intensify

October 16, 2025

New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers...

Via MarketMinute

Topics Bankruptcy Death Lawsuit

Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation

October 16, 2025

Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As...

Via MarketMinute

Topics Government Lawsuit

Discover which S&P500 stocks are making waves on Thursday. ↗

October 16, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

These S&P500 stocks are the most active in today's session ↗

October 16, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

October 16, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims ↗

October 16, 2025

Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades.

Via Benzinga

Topics Lawsuit

Johnson & Johnson Battles New UK Talc Cancer Claims Worth £1B After Massive US Verdict: Report ↗

October 15, 2025

Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off.

Via Stocktwits

Topics Bankruptcy Death Lawsuit

2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 41% in 12 Months, According to Select Wall Street Analysts ↗

October 15, 2025

Juicy dividends are only part of the attraction with these beaten-down stocks.

Via The Motley Fool

Topics Government

Albert Invent Partners with Kenvue to Build the Future of Consumer Health Products With the Help of AI

October 14, 2025

From Albert Invent

Via Business Wire

These S&P500 stocks are moving in today's session ↗

October 13, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch ↗

October 13, 2025

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

Via Benzinga

Tylenol Turmoil: Partisan Politics Fuel Confusion Over Pregnancy Risks, Poll Shows ↗

October 10, 2025

KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vaccines.

Via Benzinga

Is This Beaten-Down Dividend King a Buy? ↗

October 10, 2025

This company's short life on the stock market has been a constant challenge.

Via The Motley Fool

Topics Intellectual Property

Which S&P500 stocks are moving on Thursday? ↗

October 09, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Kenvue Inc. Common Stock (NY:KVUE)

All News about Kenvue Inc. Common Stock

Starting at $3.75/week.

Subscribe Today